Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4

INTRODUCTION: The Alzheimer's Disease Neuroimaging Initiative (ADNI) aims to validate biomarkers for Alzheimer's disease (AD) clinical trials. To improve generalizability, ADNI4 aims to enroll 50‐60% of its new participants from underrepresented populations (URPs) using new biofluid and di...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiner, Michael W., Veitch, Dallas P., Miller, Melanie J., Aisen, Paul S., Albala, Bruce, Beckett, Laurel A., Green, Robert C., Harvey, Danielle, Jack, Clifford R., Jagust, William, Landau, Susan M., Morris, John C., Nosheny, Rachel, Okonkwo, Ozioma C., Perrin, Richard J., Petersen, Ronald C., Rivera‐Mindt, Monica, Saykin, Andrew J., Shaw, Leslie M, Toga, Arthur W., Tosun, Duygu, Trojanowski, John Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042173/
https://www.ncbi.nlm.nih.gov/pubmed/36209495
http://dx.doi.org/10.1002/alz.12797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042173/
https://www.ncbi.nlm.nih.gov/pubmed/36209495
http://dx.doi.org/10.1002/alz.12797

Ejemplares similares